Comparative bioavailability of two oral nimodipine formulations after administration to 24 healthy volunteers

Clinical Drug Investigation

Volumn 17, Issue 6, 1999, Pages 475-482

  Gualano, V ^a   Ntsikoussalabongui, B ^a   Mignot, A ^a   Duvauchelle, T ^b   Felices, M ^b   Guillaume, M ^b   Orlandini, B ^b   Holguin J A ^c   Alcaide, Antonio ^c  

^a Cephac   (France)

^b Aster Cephac   (France)

^c Laboratories Andrómaco   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAINAL; NIMODIPINE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TABLET FORMULATION;

EID: 0032986369     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199917060-00008     Document Type: Article

References (10)

1. 1. Langley MS, Sorkin E. Nimodipine, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 1989; 37: 669-99
2. 2. Morich FJ, Florian B, Jeanne M, et al. Nimodipine in the treatment of probable Alzheimer's disease. Results of two multicentric trials. Clin Drug Invest 1996; 11: 185-95
3. 3. Gengo FM, Fagan SC, Krol G, et al. Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age matched controls. Br J Clin Pharmacol 1987; 23: 47-53
4. 4. Rämsch KD, Graefe KH, Scherling D, et al. Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine. J Nephrol 1986; 6: 73-80
5. 5. Gibaldi M, Perrier D, Pharmacokinetics. Vol. 15. 2nd ed. revised and expanded. Drugs and Pharmaceutical Sciences 1982. New York: Dekker
6. 6. Rowland M, Tozer T. Clinical pharmacokinetics - concepts and applications. 2nd ed. Philadelphia: Lea & Febiger, 1989
7. 7. Rowland M, Tucker G. Symbols in pharmacokinetics. J Pharm Biopharm 1980; 8: 497-507
8. 8. Endrenyi L. A method for the evaluation of individual bioequivalence. Int J Clin Pharmacol Ther 1994; 32: 497-508
9. 9. Mück W, Heine PR, Schmage N, et al. Steady-state pharmacokinetics of nimodipine during chronic administration of indomethacin in elderly healthy volunteers. Arzneimforschung Drug Res 1995; 4: 460-2
10. 2-receptor antagonist cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers. Eur J Clin Pharmacol 1992; 42: 325-8